GeneDx Holdings (WGS) Short-term Investments (2023 - 2026)

GeneDx Holdings (WGS) has reported Short-term Investments for 4 consecutive years, with $76.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 29.11% year-over-year to $76.8 million; the TTM figure through Mar 2026 stood at $76.8 million (up 29.11% YoY), while the FY2025 annual figure was $66.3 million, up 18.42% from the prior year.
• Short-term Investments grew to $76.8 million in Q1 2026 per WGS's latest filing, from $66.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $76.8 million in Q1 2026 and bottomed at $12.1 million in Q1 2023.
• Historically, Short-term Investments has averaged $48.8 million across 4 years, with a median of $57.3 million in 2024.
• Annual changes were most pronounced in 2024 — Short-term Investments surged 140.77% — and 2025, when it grew 0.93%.
• GeneDx Holdings' Short-term Investments stood at $30.5 million in 2023, then surged by 83.72% to $56.0 million in 2024, then gained by 18.42% to $66.3 million in 2025, then increased by 15.8% to $76.8 million in 2026.
• Business Quant data shows WGS's Short-term Investments at $76.8 million in Q1 2026, $66.3 million in Q4 2025, and $59.1 million in Q3 2025.